muramidase and Blood-Coagulation-Disorders

muramidase has been researched along with Blood-Coagulation-Disorders* in 3 studies

Other Studies

3 other study(ies) available for muramidase and Blood-Coagulation-Disorders

ArticleYear
Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism.
    Thrombosis and haemostasis, 2014, Mar-03, Volume: 111, Issue:3

    Apart from transporting lipids through the body, the human plasma lipoproteins very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) are also thought to serve as a modality for intra-organismal protein transfer, shipping proteins with important roles in inflammation and thrombosis from the site of synthesis to effector locations. To better understand the role of VLDL and LDL in the transport of proteins, we applied a combination of LTQ ORBITRAP-XL (nLC-MS/MS) with both in-SDS-PAGE gel and in-solution tryptic digestion of pure and defined VLDL and LDL fractions. We identified the presence of 95 VLDL- and 51 LDL-associated proteins including all known apolipoproteins and lipid transport proteins, and intriguingly a set of coagulation proteins, complement system and anti- microbial proteins. Prothrombin, protein S, fibrinogen γ, PLTP, CETP, CD14 and LBP were present on VLDL but not on LDL. Prenylcysteine oxidase 1, dermcidin, cathelicidin antimicrobial peptide, TFPI-1 and fibrinogen α chain were associated with both VLDL and LDL. Apo A-V is only present on VLDL and not on LDL. Collectively, this study provides a wealth of knowledge on the protein constituents of the human plasma lipoprotein system and strongly supports the notion that protein shuttling through this system is involved in the regulation of biological processes. Human diseases related to proteins carried by VLDL and LDL can be divided in three major categories: 1 - dyslipidaemia, 2 - atherosclerosis and vascular disease, and 3 - coagulation disorders.

    Topics: Antimicrobial Cationic Peptides; Apolipoprotein A-V; Apolipoproteins A; Atherosclerosis; Blood Coagulation; Blood Coagulation Disorders; Carbon-Sulfur Lyases; Cathepsin D; Cholesterol Ester Transfer Proteins; Computational Biology; Dyslipidemias; Humans; Lipid Metabolism; Lipopolysaccharide Receptors; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Mass Spectrometry; Muramidase; Phosphatidylcholine-Sterol O-Acyltransferase; Phospholipid Transfer Proteins; Plasma; Protein S; Proteome; Prothrombin

2014
The distinctive features of acute monocytic leukemia.
    American journal of hematology, 1978, Volume: 4, Issue:1

    Acute monocytic leukemia is an uncommon form of acute leukemia. Distinctive clinical features include gingival hypertrophy, lymphoadenopathy, coagulation disorders, and lysozymuria. Blast cell morphology and cytochemistry are diagnostic. Receptors for the Fc fragment of IgG have been demonstrated on the basis of a few cases. The drug VP 16-213 has been shown to be very effective in treatment of untreated and previously treated patients.

    Topics: Blood Coagulation Disorders; Cell Nucleus; Disseminated Intravascular Coagulation; Esterases; Etoposide; Gingival Hypertrophy; Histocytochemistry; Humans; Leukemia, Monocytic, Acute; Lymph Nodes; Monocytes; Muramidase; Prednisolone; Vinblastine; Vincristine

1978
Physiological changes of the vaccinated organism: a basis for the interpretation of the clinical complications due to prophylactic vaccines.
    Progress in immunobiological standardization, 1967, Volume: 3

    Topics: Adaptation, Physiological; Adrenocortical Hyperfunction; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bacterial Vaccines; Blood Coagulation Disorders; Blood Glucose; Blood Protein Disorders; Child; Cholesterol; Complement System Proteins; Electrolytes; Eosinophils; Humans; Hyperlipidemias; Leukocytosis; Lymphopenia; Muramidase; Neurologic Manifestations; Phagocytosis; Properdin; Thrombocytosis; Toxoids; Transferrin; Vaccination; Viral Vaccines

1967